REQUEST A DEMO
Total
USD $0.00
Search more companies

PT Medifarma Laboratories (Indonesia)

Main Activities: Medicinal and Botanical Manufacturing
Full name: PT Medifarma Laboratories Profile Updated: February 28, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2022 Available in: English Download a sample report

PT Medifarma Laboratories is based in Indonesia. The head office is in Depok. The company operates in the Medicinal and Botanical Manufacturing industry. The company was established on September 10, 1970. It currently has a total number of 485 (2012) employees. The latest financial highlights indicate a net sales revenue increase of 16.71% in 2022. Its’ total assets recorded a growth of 19.41%.

Headquarters
RT 005, RW 002
Depok; West Java; Postal Code: 16453

Contact Details: Purchase the PT Medifarma Laboratories report to view the information.

Website: http://www.medifarma.biz

Basic Information
Total Employees:
Purchase the PT Medifarma Laboratories report to view the information.
Outstanding Shares:
Purchase the PT Medifarma Laboratories report to view the information.
Registered Capital:
Purchase the PT Medifarma Laboratories report to view the information.
Incorporation Date:
September 10, 1970
Key Executives
Purchase this report to view the information.
President Director
Purchase this report to view the information.
Director
Purchase this report to view the information.
Director
Ownership Details
Purchase this report to view the information.
Purchase this report to view the information.
Company Performance
Financial values in the chart are available after PT Medifarma Laboratories report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency USD. Absolute financial data is included in the purchased report.
Net sales revenue
16.71%
Total operating revenue
16.71%
Total assets
19.41%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?